Iwatsuki, Masaaki
Orita, Hiroyuki
Kobayashi, Kazuma
Hidaka, Shigekazu
Arigami, Takaaki
Kusumoto, Tetsuya
Satake, Hironaga
Oki, Eiji http://orcid.org/0000-0002-9763-9366
Tsutsumi, Satoshi
Tobimatsu, Kazutoshi
Shimokawa, Mototsugu
Saeki, Hiroshi
Makiyama, Akitaka
Baba, Hideo
Mori, Masaki
Funding for this research was provided by:
Yakult Honsha
Article History
Received: 17 February 2021
Accepted: 12 July 2021
First Online: 11 August 2021
Declarations
:
: This study was supported by funding from Yakult Honsha Co., Ltd. S. H. Satake received research funding from Ono Pharmaceutical Co. Ltd., Daiichi Sankyo, Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Sanofi and honoraria from Bayer Co., Ltd., Bristol-Myers Squibb Co., Ltd., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eli Lilly Japan Co., Ltd., Merck Bio Pharma Co., Ltd., MSD Co., Ltd., Ono Pharmaceutical Co., Ltd., Sanofi Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Co., Ltd., and Yakult Honsha Co., Ltd. E. Oki received honoraria for lectures from Bayer Yakuhin, Ltd., Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Johnson & Johnson K.K., Merck Serono Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Yakult Honsha Co., Ltd. All remaining authors have declared no conflicts of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent to be included in the study, or the equivalent, was obtained from all patients.
Free to read: This content has been made available to all.